Court Rules
All enforcement actions
SettlementCritical RiskMultistate

State AGs Settle with Endo for $450M Over Deceptive Opioid Marketing

Endo International plcAugust 17, 2022Connecticut Attorney General

Penalty Amount

$450,000,000

Summary

State attorneys general reached a $450 million settlement with opioid manufacturer Endo International plc as part of its bankruptcy. The settlement resolves allegations of deceptive marketing that downplayed addiction risks and overstated benefits, particularly for Opana ER. Endo must pay $450 million over 10 years, ban opioid marketing forever, and disclose millions of documents.

Remedy

Endo must pay $450 million over 10 years to participating states and subdivisions, permanently ban the marketing of its opioids, and turn over millions of opioid-related documents for publication in a public online archive, including paying $2.75 million for archival expenses.

Monetary PenaltyBanReporting Requirements

Contract Impact

In-house legal teams should review vendor agreements with pharmaceutical distributors, customer agreements with healthcare providers and pharmacies, and employee contracts for sales and marketing personnel. Key clauses to examine include marketing and promotional restrictions, representations and warranties regarding product safety and efficacy, compliance with laws and regulatory actions, indemnification obligations for fines or settlements, termination provisions for misconduct, and document retention/disclosure requirements. Changes may be needed to permanently ban opioid marketing, update product claim substantiation requirements, incorporate settlement payment schedules over 10 years, enhance document production obligations for public archives, and strengthen indemnification for deceptive marketing allegations.

Contract Search Terms

marketing prohibitiondeceptive practices clauseproduct claim representationssettlement payment termsdocument disclosure requirementscompliance with regulatory actionsindemnification for finestermination for misconduct

Violation Types

Entity Details

Entity

Endo International plc

Also known as: Endo

Industry

Healthcare

Multistate Coalition

Official Sources

Related Enforcement Actions

CT

U.S. Food and Drug Administration (FDA)

On May 11, 2026, Connecticut Attorney General William Tong led a bipartisan coalition of 21 attorneys general in submitting a comment letter to the U.S. Food and Drug Administration (FDA) urging the agency to abandon draft guidance that would ease approvals for flavored e-cigarette products. The coalition argues the guidance ignores evidence that flavored e-cigarettes disproportionately drive youth addiction and that FDA has failed to enforce existing authorization requirements for e-cigarette products. The letter references past tobacco and e-cigarette enforcement actions, including the 1998 tobacco master settlement agreement and the 2022 $438.5 million settlement with JUUL Labs.

CT

Bad actor platforms

Connecticut’s legislature passed House Bill 5312, creating new civil enforcement mechanisms for deepfake digital sexual assault, including unauthorized dissemination of synthetically created intimate images and AI-generated child pornography. The bill establishes a private right of action for victims and empowers the Connecticut Attorney General to pursue civil injunctions and penalties against abusers and platforms hosting illegal content. This builds on prior Connecticut laws criminalizing unauthorized intimate image dissemination.

CT

None

Connecticut Attorney General William Tong praised final passage of House Bill 5312, which creates new civil enforcement mechanisms for deepfake digital sexual assault. The legislation allows the AG to pursue civil injunctions and penalties against platforms that disseminate illegal synthetic intimate images, including AI-generated child pornography, and establishes a private right of action for victims. The bill builds on prior Connecticut laws criminalizing unauthorized dissemination of intimate images.

CT

Made-in-China

$300K

Connecticut Attorney General William Tong announced a settlement with international trade platform Made-in-China to cease all U.S. sales of unlawful 'research grade' GLP-1 weight loss drugs following an investigation into direct sales to consumers without prescriptions or medical oversight. The settlement prohibits the platform from hosting GLP-1 sales to U.S. customers, requires a monitoring system to remove non-compliant listings, and imposes a $300,000 penalty suspended after an initial $30,000 payment. Additional settlements were announced with Radiance Medspa and Advanced Medical Weight Loss over compounded non-FDA approved GLP-1 drugs.

CT

social media companies

Connecticut Attorney General William Tong issued a statement on May 1, 2026, announcing the final passage of bipartisan legislation targeting youth social media addiction and artificial intelligence harms. The legislation imposes new obligations on social media companies regarding minor account settings, parental consent, and reporting, as well as requirements for AI chatbot operators and employers using automated decision tools. The statement also references ongoing enforcement actions against Meta and TikTok for allegedly designing addictive platform features for youth.

CT

Office of the Attorney General William Tong

Connecticut Attorney General William Tong issued a statement on May 1, 2026, following final passage of bipartisan legislation to combat youth social media addiction and regulate artificial intelligence harms. The legislation imposes new requirements on social media companies regarding minor users, including parental consent for addictive algorithms, default privacy settings, and annual reporting obligations. It also establishes rules for AI chat bots and automated employment decision tools, including disclosure requirements and self-harm detection protocols.